| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.286 | 7.207 | 21.069 | 84.565 | 129.280 | 155.920 | 229.131 | 319.947 | 326.697 | 363.968 |
| Total Income - EUR | 2.286 | 7.207 | 21.069 | 84.568 | 129.284 | 155.924 | 229.136 | 319.951 | 326.703 | 363.981 |
| Total Expenses - EUR | 1.100 | 2.426 | 7.134 | 24.238 | 34.121 | 49.730 | 86.825 | 128.305 | 208.421 | 233.144 |
| Gross Profit/Loss - EUR | 1.186 | 4.780 | 13.935 | 60.330 | 95.163 | 106.194 | 142.310 | 191.647 | 118.282 | 130.838 |
| Net Profit/Loss - EUR | 1.118 | 4.564 | 13.592 | 59.484 | 93.870 | 104.634 | 140.019 | 188.447 | 115.014 | 119.890 |
| Employees | 0 | 0 | 1 | 3 | 4 | 4 | 5 | 6 | 7 | 7 |
Check the financial reports for the company - Diab Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 676 | 11.158 | 61.914 | 108.431 | 194.849 | 239.233 | 277.047 |
| Current Assets | 768 | 5.312 | 19.791 | 78.941 | 118.233 | 113.140 | 160.786 | 201.322 | 230.067 | 224.185 |
| Inventories | 528 | 654 | 1.209 | 1.867 | 2.224 | 2.415 | 2.745 | 918 | 1.030 | 1.165 |
| Receivables | 45 | 785 | 4.702 | 7.306 | 18.876 | 1.614 | 800 | 61.662 | 39.643 | 79 |
| Cash | 195 | 3.874 | 13.880 | 69.768 | 97.132 | 109.110 | 157.241 | 138.742 | 189.394 | 222.941 |
| Shareholders Funds | -1.002 | 3.572 | 17.103 | 76.274 | 124.302 | 172.176 | 265.819 | 391.055 | 460.936 | 490.744 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.770 | 1.740 | 2.687 | 3.344 | 5.089 | 2.878 | 3.398 | 5.116 | 8.365 | 10.489 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diab Medica Srl